According to GO: molecular functions, FERMT2 was also upregulated in “Type I Transforming Growth Factor Beta Receptor Binding.” In addition, FERMT2 was downregulated by PFD treatment according to GO: biological process (Table 4a) and GO: molecular function (Table 4b). The gene discussed is FERMT2; the disease is polyostotic fibrous dysplasia.